Parenting Fears Harm Well-Being of Women With Metastatic Cancer

Share this content:
Parenting Fears Harm Well-Being of Women With Metastatic Cancer
Parenting Fears Harm Well-Being of Women With Metastatic Cancer

MONDAY, May 7, 2018 (HealthDay News) -- Among women with metastatic cancer and dependent children, parenting concerns negatively impact health-related quality of life (HRQOL), according to a study published online May 7 in Cancer.

Eliza M. Park, M.D., from the University of North Carolina at Chapel Hill, and colleagues surveyed 224 women regarding psychosocial concerns. The participants had a stage IV solid tumor cancer and at least one child aged <18 years.

The researchers found that the mean Emotional Well-Being subscale scores of the Functional Assessment of Cancer Therapy-General (FACT-G) questionnaire were particularly low. Parenting variables explained nearly 40 percent of the HRQOL model variance. FACT-G scores decreased by 4 points for each 1-point increase in parenting concern severity (P = 0.003).

"There are tens of thousands of parents in the United States living with advanced cancer, and improving their health-related quality of life is critical to patient-centered care for these individuals," Park said in a statement. "Across demographic groups, the overwhelming majority of parents of minor children identify their parental status as central to their identity. Our findings demonstrate that the parenting role is powerfully intertwined with the patient experience."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: U.S. Abortion Rate Declined 24 Percent From 2006 to 2015

CDC: U.S. Abortion Rate Declined 24 Percent From ...

Abortions among women ages 15-44 fell 26 percent, from 15.9 to 11.8 abortions per 1,000 women

U of Maryland Student Dies of Adenovirus-Related Illness

U of Maryland Student Dies of Adenovirus-Related Illness

CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness

FDA Approves Drug to Treat Rare Immune Disease

FDA Approves Drug to Treat Rare Immune Disease

Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis

is free, fast, and customized just for you!




Already a member?

Sign In Now »